,i  #aag? ,,congress  #a/ ,session  ,h4 
,r4 #dbgh  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,june #cj1 #bjba,mr4  
,murphy ( ,nor? ,c>ol9a 7= himself &    
,mrs4 ,h>%b>g]7 introduc$ ! foll[+ bill2
 :i* 0 ref]r$ to ! ,committee on ,en]gy 
& ,comm]ce  ,a ,,bill  ,to direct !     
,comptroll] ,g5]al ( ! ,unit$ ,/ates to 
conduct a /udy on h[ direct-to-consum]  
ph>maceutical adv]tis+ negatively       
impacts drug co/s to consum]s1 & = o!r  
purposes4  #a4 ,,gao /udy on h[         
direct-to-consum] ph>maceutical adv]tis+
 negatively impacts drug co/s to        
consum]s  7a7 ,9 g5]al ,n lat] ?an #ahj 
days aft] ! date ( ! enactm5t ( ?is     
,act1 ! ,comptroll] ,g5]al ( ! ,unit$   
,/ates %all conduct a /udy on h[        
direct-to-consum] ph>maceutical adv]tis+
 negatively impacts drug co/s to        
consum]s4 ,su* /udy %all focus on-- 7#a7
 :at /eps may be tak5 by ph>maceutical  
drug manufactur]s & di/ributors to r$uce
 ! high] drug co/s paid by consum]s z a 
result ( su* adv]tis+ by splitt+ ! co/ (

 adv]tis+ betwe5 ea* organization       
develop+ a p>ticul> drug2  7#b7 !       
expectations ( consum]s & pati5ts )     
respect to ! drugs s adv]tis$2 &  7#c7 !
 role su* adv]tisem5ts play 9 promot+   
m$ication to pati5ts = :om su* m$ication
 may n be necess>y4  7b7 ,report ,!     
,comptroll] ,g5]al %all-- 7#a7 submit a 
report conta9+ ! results ( ! /udy to--  
7,a7 ! ,committee on ! ,judici>y & !    
,committee on ,en]gy & ,comm]ce ( !     
,h\se ( ,repres5tatives2 &  7,b7 !      
,committee on ! ,judici>y & ! ,committee
 on ,heal?1 ,education1 ,labor1 &       
,p5sions ( ! ,s5ate2 &  7#b7 make su*   
report publicly available4